Literature DB >> 10651599

Resource use and survival of patients hospitalized with congestive heart failure: differences in care by specialty of the attending physician. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.

A D Auerbach1, M B Hamel, R B Davis, A F Connors, C Regueiro, N Desbiens, L Goldman, R M Califf, N V Dawson, N Wenger, H Vidaillet, R S Phillips.   

Abstract

BACKGROUND: Previous studies suggest that specialty care is more costly but may produce improved outcomes for patients with acute cardiac illnesses.
OBJECTIVE: To determine whether patients with congestive heart failure who are cared for by cardiologists experienced differences in costs, care patterns, and survival compared with patients of generalists.
DESIGN: Prospective cohort study.
SETTING: 5 U.S. teaching hospitals between 1989 and 1994. PATIENTS: 1298 patients hospitalized with an exacerbation of congestive heart failure. MEASUREMENTS: Hospital costs; average daily Therapeutic Intervention Scoring System (TISS) score; and survival censored at 30, 180, and 365 days and 31 December 1994.
RESULTS: Compared with patients of generalists, patients of cardiologists were younger (mean age, 63.3 and 71.4 years; P < 0.001) and had lower Acute Physiology Scores at the time of admission (35.1 and 36.7; P < 0.001) but were more likely to have a history of ventricular arrhythmias (21.0% and 10.2%; P < 0.001). At 6 months, 201 (27%) patients of cardiologists and 149 (27%) patients of generalists had died. After adjustment for sociodemographic characteristics and severity of illness, patients of cardiologists incurred costs that were 42.9% (95% CI, 27.8% to 59.8%) higher and average daily TISS scores that were 2.83 points (CI, 1.96 to 3.68 points) higher than those of patients of generalists. Patients of cardiologists were more likely to undergo right-heart catheterization (adjusted odds ratio, 2.9 [CI, 1.7 to 4.9]) or cardiac catheterization (adjusted odds ratio, 3.9 [CI, 2.4 to 6.2]) and had higher odds for transfer to an intensive care unit and electrocardiographic monitoring. Adjusted survival did not differ significantly between groups at 30 days; however, there was a trend toward improved survival among patients of cardiologists at 1 year (adjusted relative hazard, 0.82 [CI, 0.65 to 1.04]) and at maximum follow-up (adjusted relative hazard, 0.80 [CI, 0.66 to 0.96]).
CONCLUSIONS: In this observational study of patients hospitalized with congestive heart failure, cardiologist care was associated with greater costs and resource use and no difference in survival at 30 days of follow-up. Whether the trend toward better survival at longer follow-up represents differences in care or unadjusted illness severity is uncertain.

Entities:  

Mesh:

Year:  2000        PMID: 10651599     DOI: 10.7326/0003-4819-132-3-200002010-00004

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  20 in total

1.  In-hospital management of heart failure: in 10 years we have improved, but not enough.

Authors:  Sonia Ferretto; Chiara Dalla Valle; Sonia Cukon Buttignoni; Luca Brugnaro; Giovanni Maria Boffa
Journal:  Intern Emerg Med       Date:  2010-12-09       Impact factor: 3.397

Review 2.  A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods.

Authors:  Til Stürmer; Manisha Joshi; Robert J Glynn; Jerry Avorn; Kenneth J Rothman; Sebastian Schneeweiss
Journal:  J Clin Epidemiol       Date:  2005-10-13       Impact factor: 6.437

3.  Trends in market demand for internal medicine 1999 to 2004: an analysis of physician job advertisements.

Authors:  Andrew D Auerbach; Richard Chlouber; Jennifer Singler; Jon D Lurie; Alan Bostrom; Robert M Wachter
Journal:  J Gen Intern Med       Date:  2006-07-07       Impact factor: 5.128

Review 4.  Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapies.

Authors:  Emile Levy; Pierre Levy
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

5.  In-hospital cardiology consultation and evidence-based care for nursing home residents with heart failure.

Authors:  Wilbert S Aronow; Michael W Rich; Sarah J Goodlin; Thomas Birkner; Yan Zhang; Margaret A Feller; Inmaculada B Aban; Linda G Jones; Donna M Bearden; Richard M Allman; Ali Ahmed
Journal:  J Am Med Dir Assoc       Date:  2011-10-08       Impact factor: 4.669

6.  Impact of specialist follow-up in outpatients with congestive heart failure.

Authors:  Justin A Ezekowitz; Carl van Walraven; Finlay A McAlister; Paul W Armstrong; Padma Kaul
Journal:  CMAJ       Date:  2005-01-18       Impact factor: 8.262

7.  Systematic review of economic burden of heart failure.

Authors:  Asrul Akmal Shafie; Yui Ping Tan; Chin Hui Ng
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

8.  Short-term outcomes of heart failure patients with reduced and preserved ejection fraction after acute decompensation according to the final destination after emergency department care.

Authors:  Òscar Miró; V Íctor Gil; Francisco Javier Martín-Sánchez; Javier Jacob; Pablo Herrero; Aitor Alquézar; Lluís Llauger; Sira Aguiló; Gemma Martínez; José Ríos; Alberto Domínguez-Rodríguez; Veli-Pekka Harjola; Christian Müller; John Parissis; W Frank Peacock; Pere Llorens
Journal:  Clin Res Cardiol       Date:  2018-03-28       Impact factor: 5.460

9.  Specialty care use in US patients with chronic diseases.

Authors:  Jessica D Bellinger; Rahnuma M Hassan; Patrick A Rivers; Qiang Cheng; Edith Williams; Saundra H Glover
Journal:  Int J Environ Res Public Health       Date:  2010-03-10       Impact factor: 3.390

10.  Quality of care for decompensated heart failure: comparable performance between academic hospitalists and non-hospitalists.

Authors:  Eduard E Vasilevskis; David Meltzer; Jeffrey Schnipper; Peter Kaboli; Tosha Wetterneck; David Gonzales; Vineet Arora; James Zhang; Andrew D Auerbach
Journal:  J Gen Intern Med       Date:  2008-07-01       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.